Late filing
elevated
Filing comparison
NORTHWEST BIOTHERAPEUTICS INC told the SEC it could not file its annual report on time
The Company has determined that it is unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 Annual Report”) within the time period prescribed. During the final stages of the 10-K preparation process, complex issues related to the Company’s acquisition of Advent BioServices were encountered, including due to differences in UK GAAP and US GAAP. The Company is working to file the 2025 Annual Report as soon as is reasonably practicable. Cautionary Note Regarding Forward-Looking Statements This Form 12b-25 contains forward-looking statements, which are statements that relate to the future and are, by their…
Evidence
- Days past due date
- 0
- Routine
- No
- Severity
- elevated
- Source
- Form 12b-25 (notification of late filing)
- Stated reason
- The Company has determined that it is unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 Annual Report”) within the time period prescribed. During the final stages of the 10-K preparation process, complex issues related to the Company’s acquisition of Advent BioServices were encountered, including due to differences in UK GAAP and US GAAP. The Company is working to file the 2025 Annual Report as soon as is reasonably practicable. Cautionary Note Regarding Forward-Looking Statements This Form 12b-25 contains forward-looking statements, which are statements that relate to the future and are, by their…
- Why
- The company told the SEC it could not file a periodic report on time, using Form 12b-25.